Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Biophys J ; 99(10): L81-3, 2010 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-21081055

RESUMEN

Nicotinic acetylcholine receptors are some of the most studied synaptic proteins; however, many questions remain that can only be answered using single molecule approaches. Here we report our results from single α7 and neuromuscular junction type nicotinic acetylcholine receptors in mammalian cell membranes. By labeling the receptors with fluorophore-labeled bungarotoxin, we can image individual receptors and count the number of bungarotoxin-binding sites in receptors expressed in HEK 293 cells. Our results indicate that there are two bungarotoxin-binding sites in neuromuscular junction receptors, as expected, and five in α7 receptors, clarifying previous uncertainty. This demonstrates a valuable technique for counting subunits in membrane-bound proteins at the single molecule level, with nonspecialized optics and with higher signal/noise ratios than previous fluorescent protein-based techniques.


Asunto(s)
Bungarotoxinas/metabolismo , Receptores Nicotínicos/metabolismo , Sitios de Unión , Colorantes Fluorescentes/metabolismo , Células HEK293 , Humanos , Unión Neuromuscular/metabolismo , Fotoblanqueo , Receptor Nicotínico de Acetilcolina alfa 7
2.
J Neurosci ; 30(30): 10112-26, 2010 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-20668195

RESUMEN

The function of Ric-3, which is required for nicotinic acetylcholine receptor (nAChR) expression in C. elegans, is unclear. Here we found that Ric-3 can promote or inhibit cell-surface delivery of alpha-bungarotoxin-binding nAChRs (BgtRs) composed of alpha7 subunits. At low levels, Ric-3 promoted BgtR assembly, endoplasmic reticulum (ER) release, and cell-surface delivery without trafficking from the ER. At high Ric-3 levels, Ric-3 suppressed BgtR surface delivery, but not its assembly, and BgtRs were retained in the ER or in Ric-3-containing aggregates. In PC12 cells, native BgtRs trafficked to the cell surface from the ER where low levels of endogenous Ric-3 were observed. In cultured neurons, native Ric-3 levels were higher than in PC12 cells, and Ric-3 and alpha7 subunits were found in somata and dendrites, but not axons, of inhibitory interneurons. Ric-3 trafficked with alpha7 subunits in rapidly moving vesicles to dendrites, where it was restricted to the ER subcompartment. We conclude that Ric-3 has two potential functions. At low levels, Ric-3 interactions are short-lived and promote BgtR assembly and ER release. At higher levels, Ric-3 interactions are longer-lived and mediate ER retention. In neurons, Ric-3 ER retention appears to promote transport within the dendritic ER subcompartment, thereby restricting alpha7 trafficking to dendrites and preventing axonal transport.


Asunto(s)
Dendritas/ultraestructura , Retículo Endoplásmico/metabolismo , Proteínas de la Membrana/genética , Chaperonas Moleculares/genética , Acetilcolina/farmacología , Animales , Autoantígenos/metabolismo , Bungarotoxinas/metabolismo , Bungarotoxinas/farmacología , Línea Celular/citología , Células Cultivadas , Pollos , Colinérgicos/farmacología , Dendritas/efectos de los fármacos , Retículo Endoplásmico/efectos de los fármacos , Citometría de Flujo/métodos , Glutamato Descarboxilasa/metabolismo , Proteínas Fluorescentes Verdes/genética , Hipocampo/citología , Humanos , Isótopos de Yodo/metabolismo , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Modelos Biológicos , Técnicas de Placa-Clamp/métodos , Unión Proteica/efectos de los fármacos , Unión Proteica/genética , Proteína Disulfuro Isomerasas/metabolismo , Transporte de Proteínas/genética , Ratas , Receptores Nicotínicos/metabolismo , Distribución Tisular/efectos de los fármacos , Transfección/métodos , Receptor Nicotínico de Acetilcolina alfa 7
3.
J Neurosci ; 30(3): 939-49, 2010 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-20089902

RESUMEN

Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is known to contribute to the expression of psychostimulant sensitization by regulating dopamine (DA) overflow from DA neuron terminals in the nucleus accumbens (NAcc). The present experiments explored the contribution of CaMKII in NAcc neurons postsynaptic to these terminals where it is known to participate in a number of signaling pathways that regulate responding to psychostimulant drugs. Exposure to amphetamine transiently increased alphaCaMKII levels in the shell but not the core of the NAcc. Thus, HSV (herpes simplex viral) vectors were used to transiently overexpress alphaCaMKII in NAcc neurons in drug-naive rats, and behavioral responding to amphetamine was assessed. Transiently overexpressing alphaCaMKII in the NAcc shell led to long-lasting enhancement of amphetamine-induced locomotion and self-administration manifested when alphaCaMKII levels were elevated and persisting long after they had returned to baseline. Enhanced locomotion was not observed after infection in the NAcc core or sites adjacent to the NAcc. Transient elevation of NAcc shell alphaCaMKII levels also enhanced locomotor responding to NAcc AMPA and increased phosphorylation levels of GluR1 (Ser831), a CaMKII site, both soon and long after infection. Similar increases in pGluR1 (Ser831) were observed both soon and long after exposure to amphetamine. These results indicate that the transient increase in alphaCaMKII observed in neurons of the NAcc shell after viral-mediated gene transfer and likely exposure to amphetamine leads to neuroadaptations in AMPA receptor signaling in this site that may contribute to the long-lasting maintenance of behavioral and incentive sensitization by psychostimulant drugs like amphetamine.


Asunto(s)
Anfetaminas/farmacología , Conducta Animal/efectos de los fármacos , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/metabolismo , Estimulantes del Sistema Nervioso Central/farmacología , Expresión Génica/fisiología , Núcleo Accumbens/efectos de los fármacos , Análisis de Varianza , Animales , Ácido Aspártico/genética , Proteína de Unión a CREB/metabolismo , Proteína Quinasa Tipo 2 Dependiente de Calcio Calmodulina/genética , Condicionamiento Operante/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Técnicas de Transferencia de Gen , Masculino , Actividad Motora/efectos de los fármacos , Ratas , Ratas Long-Evans , Ratas Sprague-Dawley , Receptores AMPA/genética , Receptores AMPA/metabolismo , Autoadministración/métodos , Serina/metabolismo , Treonina/genética , Factores de Tiempo
4.
Methods ; 40(2): 127-34, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17012024

RESUMEN

Protein palmitoylation plays an important role in the structure and function of a wide array of proteins. Unlike other lipid modifications, protein palmitoylation is highly dynamic and cycles of palmitoylation and depalmitoylation can regulate protein function and localization. The dynamic nature of palmitoylation is poorly resolved because of limitations in assay methods. Here, we discuss various methods that can be used to measure protein palmitoylation and identify sites of palmitoylation. We describe new methodology based on "fatty acyl exchange labeling" in which palmitate is removed via hydroxylamine-mediated cleavage of the palmitoyl-thioester bond and then exchanged with a sulfhydryl-specific labeling compound. The techniques are highly sensitive and allow for quantitative estimates of palmitoylation. Unlike other techniques used to assay posttranslational modifications, the techniques we have developed can label all sites of modification with a variety of probes, radiolabeled or non-radioactive, and can be used to assay the palmitoylation of proteins from tissue samples.


Asunto(s)
Ácido Palmítico/análisis , Proteínas/análisis , Transferasas/análisis , Alquilación , Animales , Humanos , Ácido Palmítico/metabolismo , Proteínas/metabolismo , Saccharomyces cerevisiae/enzimología , Transferasas/fisiología
5.
Glia ; 53(5): 563-6, 2006 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-16355369

RESUMEN

During development, postmigratory, premyelinating oligodendrocytes extend processes that navigate through the central nervous system (CNS) environment, where they recognize a number of extracellular cues, including axonal segments to be myelinated. Ultimately this recognition event leads to the formation of the CNS myelin sheath. However, the morphological structures and molecular mechanisms that control such oligodendroglial pathfinding are poorly understood. Here we show that postmigratory, premyelinating oligodendrocyte processes possess at their distal tips expansions that ultrastructurally resemble growth cones of postmigratory neurons and that we will refer to as OLG-growth cones. OLG-growth cones are highly motile and capable of mediating process outgrowth, retraction, and branching. In addition, they express regulators of cytoskeletal organization, GAP43 and cofilin, that are known to mediate neuronal growth cone navigation. In a choice situation, processes of postmigratory, premyelinating oligodendrocytes and their OLG-growth cones have the ability to selectively avoid a nonpermissive substrate, that is, collagen IV. Thus, our findings provide, for the first time, a detailed characterization of sensorimotor structures present at the tips of postmigratory, premyelinating oligodendrocyte processes. Furthermore, the data presented here suggest that, although the cellular mechanisms involved in growth cone steering may be similar for postmigratory neuronal and oligodendroglial cells, extracellular cues may be interpreted in a cell-type-specific fashion.


Asunto(s)
Conos de Crecimiento/fisiología , Neuronas Motoras/fisiología , Vaina de Mielina/fisiología , Neuronas Aferentes/fisiología , Oligodendroglía/fisiología , Factores Despolimerizantes de la Actina/metabolismo , Animales , Movimiento Celular , Células Cultivadas , Proteína GAP-43/biosíntesis , Conos de Crecimiento/metabolismo , Conos de Crecimiento/ultraestructura , Neuronas Motoras/metabolismo , Neuronas Motoras/ultraestructura , Vaina de Mielina/metabolismo , Vaina de Mielina/ultraestructura , Neuronas Aferentes/metabolismo , Neuronas Aferentes/ultraestructura , Oligodendroglía/metabolismo , Oligodendroglía/ultraestructura , Ratas
6.
Neuron Glia Biol ; 2(2): 93-103, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-18458757

RESUMEN

The extension and directionality of neurite outgrowth are key to achieving successful target connections during both CNS development and during the re-establishment of connections lost after neural trauma. The degree of axonal elongation depends, in large part, on the spatial arrangement of astrocytic processes rich in growth-promoting proteins. Because astrocytes in culture align their processes on exposure to an electrical field of physiological strength, we sought to determine the extent to which aligned astrocytes affect neurite outgrowth. To this end, dorsal root ganglia cells were seeded onto cultured rat astrocytes that were pre-aligned by exposure to an electric field of physiological strength (500 mV mm(-1)). Using confocal microscopy and digital image analysis, we found that neurite outgrowth at 24 hours and at 48 hours is enhanced significantly and directed consistently along the aligned astrocyte processes. Moreover, this directed neurite outgrowth is maintained when grown on fixed, aligned astrocytes. Collectively, these results indicate that endogenous electric fields present within the developing CNS might act to align astrocyte processes, which can promote and direct neurite growth. Furthermore, these results demonstrate a simple method to produce an aligned cellular substrate, which might be used to direct regenerating neurites.

8.
Mol Cell Neurosci ; 27(2): 140-50, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15485770

RESUMEN

Myelination within the central nervous system (CNS) involves substantial morphogenesis of oligodendrocytes requiring plastic changes in oligodendrocyte-extracellular matrix (ECM) interactions, that is, adhesion. Our previous studies indicated that a regulator of such adhesive plasticity is oligodendrocyte-released phosphodiesterase-I alpha/autotaxin (PD-I alpha/ATX). We report here, that PD-I alpha/ATX's adhesion antagonism is mediated by a protein fragment different from the one that stimulates tumor cell motility. Furthermore, PD-I alpha/ATX's adhesion-antagonizing fragment causes a reorganized distribution of the focal adhesion components vinculin and paxillin and an integrin-dependent reduction in focal adhesion kinase (FAK) phosphorylation at tyrosine residue 925 (pFAK-925). In vivo, a similar reduction in pFAK-925 occurs at the onset of myelination when PD-I alpha/ATX expression is significantly upregulated. Most importantly, it can also be induced by the application of exogenous PD-I alpha/ATX. Our data, therefore, suggest that PD-I alpha/ATX participates in the regulation of myelination via a novel signaling pathway leading to changes in integrin-dependent focal adhesion assembly and consequently oligodendrocyte-ECM interactions.


Asunto(s)
Citoesqueleto/metabolismo , Glucosa-6-Fosfato Isomerasa/metabolismo , Glicoproteínas/metabolismo , Complejos Multienzimáticos/metabolismo , Fibras Nerviosas Mielínicas/metabolismo , Hidrolasas Diéster Fosfóricas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Animales , Células Cultivadas , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 1 , Citoesqueleto/efectos de los fármacos , Femenino , Quinasa 1 de Adhesión Focal , Proteína-Tirosina Quinasas de Adhesión Focal , Glucosa-6-Fosfato Isomerasa/farmacología , Glicoproteínas/farmacología , Complejos Multienzimáticos/farmacología , Fibras Nerviosas Mielínicas/efectos de los fármacos , Fosfodiesterasa I , Hidrolasas Diéster Fosfóricas/fisiología , Fosforilación/efectos de los fármacos , Embarazo , Pirofosfatasas , Ratas , Ratas Sprague-Dawley
9.
Brain Res ; 1007(1-2): 29-38, 2004 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-15064133

RESUMEN

Current strategies for repairing the adult CNS following injury include cell transplantation and/or the use of viral vectors to deliver therapeutic agents. Although promising, both techniques are limited in their usefulness due to the immunological response triggered in the brain as a result of the introduction of foreign antigens. An alternative method to repair the damaged CNS is to stimulate endogenous cells within the brain to divide thereby replacing cells lost to injury. Since it has been shown that growth factors such as epidermal growth factor (EGF) are potent mitogens to CNS cells in vitro, we sought to assess the mitogenic effect of an in vivo application of EGF to the adult mammalian brain. Accordingly, varying doses of human recombinant EGF were administered to the striatum of adult rats, followed 48 h later by intraperitoneal injections of 5-bromodeoxyuridine (BrdU), a marker for cell proliferation. Of four doses assessed, 0.05 ng of EGF induced the highest levels of cell proliferation. To determine the cellular identity of these proliferating cells, animals were injected with (3)H-thymidine 48 h following EGF administration to label dividing cells. Sections were subsequently immunostained for markers to astrocytes, microglia, oligodendrocytes, neural precursors, and mature neurons. Compared to controls, a significant proportion of the newly generated cells resulting from EGF administration were identified as immature and mature astrocytes. Collectively, these results provide valuable information for utilizing a growth factor administration approach to mobilize the proliferative response of endogenous cells to replace those lost to injury or disease.


Asunto(s)
Cuerpo Estriado/citología , Factor de Crecimiento Epidérmico/farmacología , Neuronas/efectos de los fármacos , Animales , Autorradiografía/métodos , Bromodesoxiuridina/metabolismo , Recuento de Células/métodos , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Ectodisplasinas , Factor de Crecimiento Epidérmico/administración & dosificación , Proteína Ácida Fibrilar de la Glía/metabolismo , Humanos , Inmunohistoquímica/métodos , Proteínas de Filamentos Intermediarios/metabolismo , Masculino , Proteínas de la Membrana/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Nestina , Neuroglía/metabolismo , Neuronas/citología , Fosfopiruvato Hidratasa/metabolismo , Ratas , Ratas Wistar , Coloración y Etiquetado/métodos , Timidina/farmacocinética , Tritio/farmacocinética , Vimentina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...